MedPath

Duodair

Brand Name: Duodair

Generic Name: Salbutamol (as sulfate) + Ipratropium (as bromide)

Active
Registration Number

DRP-11882-02

Dosage Form

Solution for Inhalation

Issuance Date

March 1, 2024

Expiry Date

May 16, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2.5 mg/500 mcg per 2.5 mL
Packaging5 mL LDPE Vial in Aluminum Foil Pouch x 7's / (Box of 7's and Box of 35’s)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Adrenergics in combination with anticholinergic
A
Application
CLIDP Conversion
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Salbutamol (as sulfate)Active
Ipratropium (as bromide)Active
Monograph: ipratropium (as bromide)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform